SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS) -- Ignore unavailable to you. Want to Upgrade?


To: Tomato who wrote (353)10/18/2000 10:29:24 AM
From: Geigartt  Read Replies (1) | Respond to of 1833
 
Yeeooow. Dow is down 270, Naz is down another 60; I'm so glad I bought this stock. I've only lost .10 - .15 /share, is that a positive sign for us? <g> while those big druggies are losing $4-5 a day. CRA is below 60 now.

On a serious note. Anybody out there have other concept stocks they are watching? I wouldn't put my IRA in them, but I love watching these little guys. And if there are more unique situations like KDUS, which has some semblance of reality (i.e., cash and a product or technology that professionals believe in) behind it, I would love hear of them.

Thanks.



To: Tomato who wrote (353)10/20/2000 5:20:18 PM
From: Tomato  Read Replies (1) | Respond to of 1833
 
A dumb question and a not so dumb question:

1. largely potential royalty flow from the OSIP-proprietary and OSIP-Solvay projects

How does that royalty flow begin? Is someone paying royalties now besides the $100k licensing fee? Who and what will cause the flow to flow? I think I read on one post that it might be over $10 mil year in 2004-2005? What gets KDUS to $10 mil in royalties?

2. Is there any time limit on Glass doing anything to "enhance SH value"? Can he sit on things indefinitely, or is there anything that compels him to shop the shell, as it were? Could we be waiting years for something to happen?

(You figure which was the dumb one(s). ;-) )